BioMarin Pharmaceuticals Fellowship in Regulatory Affairs and Policy


The Howard University College of Pharmacy, in collaboration with Biomarin Pharmaceuticals and the Food and Drug Administration (FDA) have developed a Fellowship in Regulatory Affairs and Policy. This is a comprehensive program designed to develop highly competent pharmacy professionals in regulatory affairs and policy. This fellowship program seeks to attract qualified candidates with a background in the field of pharmacy, such as PharmD degree holders, who wish to gain extensive training in regulatory affairs and policy. Candidates will have the opportunity to gain hands on experience in regulatory affairs and policy by working alongside FDA and industry professionals to address real-world challenges. 


Established in 1997, BioMarin is a world leader in developing and commercializing first or best in class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and life-threatening conditions where we can significantly improve upon the current standard of care. Our culture revolves around the ethos that no disease should go untreated, and our people are driven to discover, develop and commercialize medicines that give patients, their families, and their caregivers hope where there was little or none. We fuel our R&D engine by looking for opportunities that align with our strengths and competencies. And we relentlessly pursue exciting, early-stage science that has the potential to change the course of disease. 


Fellows will spend predetermined time at Howard University, BioMarin, with the FDA. Fellows will matriculate in the Law School of Legislation & Regulation and Administrative Law. They will also advance their knowledge on research and design methods, sit on the Institutional Review Board, complete a training certificate, and sit for the Regulatory Affairs Certification Examination. In addition, the fellow will gain on the job experience and participate in at least three rotation assignments at BioMarin and then close their experience with six-month rotation at the FDA in either patient labeling or regulatory policy. 


  • Curriculum Vitae
  • Letter of Intent 
  • Official Transcript 
  • 3 Letters of Recommendation 


Graduated with PharmD or Ph.D.